Tenascin-X is a novel diagnostic marker of malignant mesothelioma - Wikidata - awgldk - TriplyDB

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

http://www.wikidata.org/entity/Q24649948

about

Transcriptional regulation of tenascin genes Mesothelioma - Update on Diagnostic Strategies Stromal proteome expression profile and muscle-invasive bladder cancer research.Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis.PINCH-2 expression in cancers involving serosal effusions using quantitative PCR.The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma.Diagnostic molecular biomarkers for malignant pleural effusions.Immunocytochemistry: an indispensable technique in routine cytology.β-catenin expression in benign and malignant pleural disorders.DNA methylation profiles in African American prostate cancer patients in relation to disease progression.Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma.The diagnostic role of PTEN and ARID1A in serous effusions.Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling.Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?

P2860

Q26849961-A47FE11A-413D-414B-88AF-4CFE95B66F5A Q28392693-017271A3-2CD3-41FE-8937-5FCF672F4E7F Q34392967-43A33BA8-EB13-4C8E-A08F-2432C5D9E67B Q34939050-1B43A1E0-C4F8-4D40-A996-5FFE33815AFA Q35576881-82840565-2B3D-4DEE-9298-AB00FD9A03C0 Q37813173-35E586B3-C3C5-4022-A9E8-428AC2A7DC74 Q37889963-FADBF367-41C6-48AE-992F-3D4A4A4FB211 Q37902694-C8539447-F28B-4050-A9FE-206891761513 Q39431961-4CD70F03-9D68-43EF-81FA-53CA3F0D2D79 Q40894878-70FA775B-BACC-43FA-A7CD-6CDF20170115 Q44052187-4CD98C2D-64B9-43A2-86D3-B4D12D936088 Q47369086-3CC7F65D-AE00-4213-923A-1823ECBACFFF Q47988612-D61944F9-E455-433A-A1A4-A1DC5C6FCBE9 Q49986892-5956B80D-A70C-4209-8BD2-A6ED8935DD43 Q55053673-5EB20DC5-8F7A-463B-A91F-37089C604730

P2860

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

http://www.wikidata.org/entity/Q24649948

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@ast

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@en

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@nl

type

label

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@ast

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@en

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@nl

prefLabel

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@ast

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@en

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@nl

P1433

Q24649948-7E65B467-09B8-444C-9546-EF7FE759EB8C

P1476

Q24649948-41269A3F-1AFC-499A-B60C-9A3D1672F235

P2093

Q24649948-437A8267-AB8C-4DAC-8FA9-AAE2AE4CCC46

Q24649948-6EA739FB-C749-415A-941B-6BE6A64AF7FC

Q24649948-7B948FAD-899D-4FC7-BF19-6AA32356B762

Q24649948-B4E32965-3342-4F69-8A76-632BD2919CD2

Q24649948-D03AF96E-42F8-4A13-9932-989933DB785B

Q24649948-F182FA5B-0EC9-480B-A497-5179A9539882

Q24649948-F9E2B44E-D87A-4CD7-9841-EBD3E63E2F74

P2860

Q24649948-1B95E2B1-9B98-449F-B9C5-A0E3211F1DAB

Q24649948-1C66935F-CF95-45F3-848C-B4F9B36CEA97

Q24649948-37AA2463-6091-4F74-B3B4-BABE56B111B5

Q24649948-3B6E0DD6-118A-4E50-8330-37C6DE3DD666

Q24649948-3E17DEC8-D458-45A8-B60D-164BC7B4DEDF

Q24649948-70816307-E90B-4A1D-A874-34D3757723BB

Q24649948-93091086-5095-4823-AA3B-C5A8957D365F

Q24649948-AE288078-464B-436D-8D0F-5B0D6DE1D150

Q24649948-B102A12C-4338-4A3E-8014-8F33195C01A7

Q24649948-BE6189CC-6026-402D-93F2-F3E3F2A7B253

P304

Q24649948-21F74FC8-8F46-4E25-BB52-7DD853B3ADB5

P31

Q24649948-8423145F-1E87-4CE8-A510-71055B2C1838

P356

Q24649948-0311520B-3435-46B8-8826-2334B32EF823

P407

Q24649948-2DCD5536-FFF2-4F31-A2C6-876971A2CFCC

P433

Q24649948-7B9463E7-38F1-4591-94D8-56BCF81D019A

P478

Q24649948-744F0C20-238F-4F71-8BC6-AEED892E2319

P50

Q24649948-44219E11-ACAB-460F-AA88-6203DCBF694C

P577

Q24649948-DE08C311-3FD2-41A7-BF7B-BBA70585574C

P698

Q24649948-29AEB580-5DA9-4A2B-A9E2-B31FE38BA757

P921

Q24649948-bc2f15cf-4620-46c2-b748-a50a151b19a5

P932

Q24649948-0EE24698-2EEF-4533-B1D4-78B309D877B9

P356

PAS.0B013E3181B6BDE3

P1433

The American Journal of Surgical Pathology

P1476

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

@en

P2093

Anne Katrine Rosnes

http://www.w3.org/2001/XMLSchema#string

Ben Davidson

http://www.w3.org/2001/XMLSchema#string

Chuanyue Wu

http://www.w3.org/2001/XMLSchema#string

Dag André Nymoen

http://www.w3.org/2001/XMLSchema#string

Helene Tuft Stavnes

http://www.w3.org/2001/XMLSchema#string

Ola Bjørang

http://www.w3.org/2001/XMLSchema#string

Yuan Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome

Tenascin-C induced signaling in cancer

Meet the tenascins: multifunctional and mysterious

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Immunocytochemistry in effusion cytology: a contemporary review.

Application of immunohistochemistry to the diagnosis of malignant mesothelioma.

Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update.

What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update.

Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma.

Biological characteristics of cancers involving the serosal cavities.

P304

1673-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAS.0B013E3181B6BDE3

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Jahn M. Nesland

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19738457

http://www.w3.org/2001/XMLSchema#string

P921

P932

2783994

http://www.w3.org/2001/XMLSchema#string